Klebe S - Search Results

1

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.

Henderson DW, Reid G, Kao SC, van Zandwijk N, Klebe S. Henderson DW, et al. Among authors: klebe s. J Clin Pathol. 2013 Oct;66(10):854-61. doi: 10.1136/jclinpath-2013-201609. Epub 2013 Jul 6. J Clin Pathol. 2013. PMID: 23833051 Review.

2

Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.

Klebe S, Mahar A, Henderson DW, Roggli VL. Klebe S, et al. Mod Pathol. 2008 Sep;21(9):1084-94. doi: 10.1038/modpathol.2008.125. Epub 2008 Jun 27. Mod Pathol. 2008. PMID: 18587319 Free article.

3

Diagnosis of epithelial mesothelioma using tree-based regression analysis and a minimal panel of antibodies.

Klebe S, Nurminen M, Leigh J, Henderson DW. Klebe S, et al. Pathology. 2009 Feb;41(2):140-8. doi: 10.1080/00313020802579250. Pathology. 2009. PMID: 19152187

4

Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.

Klebe S, Brownlee NA, Mahar A, Burchette JL, Sporn TA, Vollmer RT, Roggli VL. Klebe S, et al. Mod Pathol. 2010 Mar;23(3):470-9. doi: 10.1038/modpathol.2009.180. Epub 2010 Jan 15. Mod Pathol. 2010. PMID: 20081811 Free article.

5

Malignant pleural mesothelioma with associated minimal change disease and acute renal failure.

Li JY, Yong TY, Kuss BJ, Klebe S, Kotasek D, Barbara JA. Li JY, et al. Among authors: klebe s. Ren Fail. 2010;32(8):1012-5. doi: 10.3109/0886022X.2010.502275. Ren Fail. 2010. PMID: 20722572 Free article.

6

Validation of tissue microarray technology in malignant pleural mesothelioma.

Kao SC, Lee K, Armstrong NJ, Clarke S, Vardy J, van Zandwijk N, Reid G, Burn J, McCaughan BC, Henderson DW, Klebe S. Kao SC, et al. Among authors: klebe s. Pathology. 2011 Feb;43(2):128-32. doi: 10.1097/PAT.0b013e328342016c. Pathology. 2011. PMID: 21233673

7

Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma.

Kao SC, Yan TD, Lee K, Burn J, Henderson DW, Klebe S, Kennedy C, Vardy J, Clarke S, van Zandwijk N, McCaughan BC. Kao SC, et al. Among authors: klebe s. J Thorac Oncol. 2011 Mar;6(3):602-5. doi: 10.1097/JTO.0b013e31820ce2c7. J Thorac Oncol. 2011. PMID: 21266919 Free article.

8

Molecular biomarkers in malignant mesothelioma: state of the art.

Kao SC, Reid G, van Zandwijk N, Henderson DW, Klebe S. Kao SC, et al. Among authors: klebe s. Pathology. 2011 Apr;43(3):201-12. doi: 10.1097/PAT.0b013e3283445e67. Pathology. 2011. PMID: 21436629 Review.

9

Early stages of mesothelioma, screening and biomarkers.

Klebe S, Henderson DW. Klebe S, et al. Recent Results Cancer Res. 2011;189:169-93. doi: 10.1007/978-3-642-10862-4_10. Recent Results Cancer Res. 2011. PMID: 21479901 Review.

10

Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma.

Kao SC, Griggs K, Lee K, Armstrong N, Clarke S, Vardy J, van Zandwijk N, Burn J, McCaughan BC, Henderson DW, Klebe S. Kao SC, et al. Among authors: klebe s. Pathology. 2011 Jun;43(4):313-7. doi: 10.1097/PAT.0b013e32834642da. Pathology. 2011. PMID: 21532523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters